Menu

News

  • Jun 22, 2017
    The Las Vegas Review-Journal: “Lumpectomies offer equally promising survival rates for breast cancer”
    Breast surgeons Dr. Dennis Holmes and Dr. Annabel Barber on “dispelling fears with facts” and the emerging technology, such as MarginProbe, that is helping make that the case. “The impulse to opt for a mastectomy or even double mastectomy after receiving a breast cancer diagnosis is understandable: You’ve just been told you have cancer, and you want it out. You might also think that by removing as much breast tissue as possible, you’re improving your chances of beating the disease....
    READ MORE
  • Jun 13, 2017
    Dune Medical’s MarginProbe “Revolutionizing Breast Cancer Treatment”
    The MarginProbe advantage and RF Spectroscopy featured as one of the most significant advancements in breast cancer treatment in recent years during I24 News. At Dune Medical Devices, improving the standard of care around cancer surgery is what we strive for each and every day. In a segment featured during I24 News’ “Crossroads with Michelle Makori and David Shuster,” MarginProbe was highlighted as “one of the most significant advancements in breast cancer surgery in recent years.” Makori and Shuster...
    READ MORE
  • Jun 8, 2017
    New clinical research shows MarginProbe reduces re-excision rates for breast conserving surgery by 61%
    A study recently presented during the 2017 American Society of Breast Surgeons annual meeting demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant difference in the total re-excision rate during breast conserving surgery- the standard option for patients with early stage breast cancer. Re-excision rates vary substantially, however, the recently reported average across multiple institutions was 25%. Research led by Amanda Kupstas, MD, Warda Ibrar, MD, D. Richard Hayward, PhD, Daniel Ockner,...
    READ MORE
  • Jun 1, 2017
    Insights from Renowned Breast Cancer Surgeon, Dr. Dennis Holmes, Given During ASBrS 2017
    During the American Society of Breast Surgeons annual meeting, Dr. Dennis Holmes, MD, internationally renowned breast cancer surgeon, researcher and innovator, was interviewed by the Co-Founder of Breast Cancer Answers, Todd Hartley. The Facebook live stream touched on multiple topics in breast oncology including what patients should know about lumpectomy and the path to treatment when diagnosed with breast cancer. Dr. Holmes is a MarginProbe advocate, and also used this opportunity to talk about his experience utilizing RF spectroscopy...
    READ MORE
  • May 25, 2017
    Challenges, controversies, and advancements in breast surgery: Insights from ASBrS 2017
    The American Society of Breast Surgeons (ASBrS) Annual meeting is the premier event of the year for surgeons who treat breast disease: hosting thousands of surgeons, medical device companies, thought leaders, and academics seeking the latest advancements and learnings in breast surgery. Leaders gathered together in Las Vegas from April 26 to 30. This year the annual meeting boasted attendance of over 1700 - the highest attended edition yet. In addition to catching up with existing and prospective MarginProbe...
    READ MORE
×
X
- Enter Your Location -
- or -
Search